Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Background

Cryptococcosis is a severe but rare opportunistic fungal infection predominantly affecting immunocompromised individuals, such as post-transplant patients. The diagnosis is frequently delayed due to non-specific symptoms and lower incidence than other fungal infections.

Case Report

A case of a 50-year-old male renal transplant recipient who developed disseminated cryptococcosis complicated by multi-organ failure is presented. Despite adherence to international treatment guidelines, the patient's condition rapidly deteriorated due to the extensive immunosuppression required for transplant rejection management. The patient developed pneumonia and was diagnosed with disseminated cryptococcosis on the 10th day of hospitalization, with identified in the pulmonary system and pleura. The patient underwent multiple interventions, including bronchoscopy, lobectomy, and pneumonectomy. Despite aggressive treatment, the infection progressed, leading to severe complications, such as neurological decline, gastrointestinal bleeding, and ultimately, multi-organ failure. The patient passed away after 53 days of hospitalization.

Conclusion

This report highlights the importance of early diagnosis and multidisciplinary management in post-transplant patients with suspected opportunistic infections. The high mortality associated with disseminated cryptococcosis, particularly in severely immunosuppressed patients, underscores the need for vigilance and prompt intervention to improve patient outcomes.

© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056353324250302180953
2025-03-25
2025-10-31
Loading full text...

Full text loading...

/deliver/fulltext/cmir/21/1/CMIR-21-E15734056353324.html?itemId=/content/journals/cmir/10.2174/0115734056353324250302180953&mimeType=html&fmt=ahah

References

  1. SinghN. AlexanderB.D. LortholaryO. DromerF. GuptaK.L. JohnG.T. del BustoR. KlintmalmG.B. SomaniJ. LyonG.M. PursellK. StosorV. MuñozP. LimayeA.P. KalilA.C. PruettT.L. Garcia-DiazJ. HumarA. HoustonS. HouseA.A. WrayD. OrloffS. DowdyL.A. FisherR.A. HeitmanJ. WagenerM.M. HusainS. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.Clin. Infect. Dis.2008462e12e1810.1086/52473818171241
    [Google Scholar]
  2. WilmesD. CocheE. Rodriguez-VillalobosH. KanaanN. Fungal pneumonia in kidney transplant recipients.Respir. Med.202118510649210.1016/j.rmed.2021.10649234139578
    [Google Scholar]
  3. PappasP.G. AlexanderB.D. AndesD.R. HadleyS. KauffmanC.A. FreifeldA. AnaissieE.J. BrumbleL.M. HerwaldtL. ItoJ. KontoyiannisD.P. LyonG.M. MarrK.A. MorrisonV.A. ParkB.J. PattersonT.F. PerlT.M. OsterR.A. SchusterM.G. WalkerR. WalshT.J. WannemuehlerK.A. ChillerT.M. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET).Clin. Infect. Dis.20105081101111110.1086/65126220218876
    [Google Scholar]
  4. GuptaK. BagaiS. RamachandranR. KumarV. RathiM. KohliH. SharmaA. ChakrabartiA. Fungal infection in post-renal transplant patient: Single-center experience.Indian J. Pathol. Microbiol.202063458759210.4103/IJPM.IJPM_306_1933154310
    [Google Scholar]
  5. MeenaP. BhargavaV. SinghK. sethiJ. PrabhakarA. pandaS. Cryptococcosis in kidney transplant recipients: Current understanding and practices.World J. Nephrol.202312512013110.5527/wjn.v12.i5.12038230297
    [Google Scholar]
  6. SalazarA.S. KellerM.R. OlsenM.A. NickelK.B. GeorgeI.A. LarsonL. PowderlyW.G. SpecA. Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort study.EClinicalMedicine20202710056310.1016/j.eclinm.2020.10056333205031
    [Google Scholar]
  7. ChangC.C. HarrisonT.S. BicanicT.A. ChayakulkeereeM. SorrellT.C. WarrisA. HagenF. SpecA. OladeleR. GovenderN.P. ChenS.C. ModyC.H. GrollA.H. ChenY.C. LionakisM.S. AlanioA. CastañedaE. LizarazoJ. VidalJ.E. TakazonoT. HoeniglM. AlffenaarJ.W. GangneuxJ.P. SomanR. ZhuL.P. BonifazA. JarvisJ.N. DayJ.N. KlimkoN. Salmanton-GarcíaJ. JouvionG. MeyaD.B. LawrenceD. RahnS. BongominF. McMullanB.J. SpruteR. NyazikaT.K. BeardsleyJ. CarlesseF. HeathC.H. AyanlowoO.O. MashediO.M. Queiroz-Telles FilhoF. HosseinipourM.C. PatelA.K. TemfackE. SinghN. CornelyO.A. BoulwareD.R. LortholaryO. PappasP.G. PerfectJ.R. Global guideline for the diagnosis and management of cryptococcosis: An initiative of the ECMM and ISHAM in cooperation with the ASM.Lancet Infect. Dis.2024248e495e51210.1016/S1473‑3099(23)00731‑438346436
    [Google Scholar]
  8. MayR.C. StoneN.R.H. WiesnerD.L. BicanicT. NielsenK. Cryptococcus: From environmental saprophyte to global pathogen.Nat. Rev. Microbiol.201614210611710.1038/nrmicro.2015.626685750
    [Google Scholar]
  9. ChaturvediV. ChaturvediS. Cryptococcus gattii: A resurgent fungal pathogen.Trends Microbiol.2011191156457110.1016/j.tim.2011.07.01021880492
    [Google Scholar]
  10. DonnellyJ.P. ChenS.C. KauffmanC.A. SteinbachW.J. BaddleyJ.W. VerweijP.E. ClancyC.J. WingardJ.R. LockhartS.R. GrollA.H. SorrellT.C. BassettiM. AkanH. AlexanderB.D. AndesD. AzoulayE. BialekR. BradsherR.W.Jr BretagneS. CalandraT. CaliendoA.M. CastagnolaE. CrucianiM. Cuenca-EstrellaM. DeckerC.F. DesaiS.R. FisherB. HarrisonT. HeusselC.P. JensenH.E. KibblerC.C. KontoyiannisD.P. KullbergB.J. LagrouK. LamothF. LehrnbecherT. LoefflerJ. LortholaryO. MaertensJ. MarchettiO. MarrK.A. MasurH. MeisJ.F. MorriseyC.O. NucciM. Ostrosky-ZeichnerL. PaganoL. PattersonT.F. PerfectJ.R. RacilZ. RoilidesE. RuhnkeM. ProkopC.S. ShohamS. SlavinM.A. StevensD.A. ThompsonG.R.III VazquezJ.A. ViscoliC. WalshT.J. WarrisA. WheatL.J. WhiteP.L. ZaoutisT.E. PappasP.G. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.Clin. Infect. Dis.20207161367137610.1093/cid/ciz100831802125
    [Google Scholar]
  11. ThambiduraiL. PrabhuradhanR. SinghviP. IlanchezhianS. RamachandranR. ShankarH. Cryptococcal pneumonia: The great mimicker.BJR Case Rep.2017322015035810.1259/bjrcr.2015035830363287
    [Google Scholar]
  12. WangH. HanW. YangC. HuH. ZhengY. HeL. ZhuM. TuQ. NanL. HuF. LiW. TangY. WangM. Clinical characteristics of pulmonary cryptococcosis patients with different immune statuses: A 10-year multicenter retrospective study in China.Respir. Med.202423510786610.1016/j.rmed.2024.10786639551250
    [Google Scholar]
  13. NovotnáM. KmentM. ViklickýO. Antibody-mediated rejection of renal allografts: Diagnostic pitfalls and challenges.Physiol. Res.202170Suppl. 4S551S56510.33549/physiolres.93480135199543
    [Google Scholar]
  14. SchinstockC.A. MannonR.B. BuddeK. ChongA.S. HaasM. KnechtleS. LefaucheurC. MontgomeryR.A. NickersonP. TulliusS.G. AhnC. AskarM. CrespoM. ChadbanS.J. FengS. JordanS.C. ManK. MengelM. MorrisR.E. O’DohertyI. OzdemirB.H. SeronD. TamburA.R. TanabeK. TaupinJ.L. O’ConnellP.J. Recommended treatment for antibody-mediated rejection after kidney transplantation: The 2019 expert consensus from the transplantion society working group.Transplantation2020104591192210.1097/TP.000000000000309531895348
    [Google Scholar]
  15. CrespoM. SoléM. ArósteguiJ.I. LozanoM. MartorellJ. OppenheimerF. Post-renal transplantatation humoral acute rejection or anti-HLA antibodies-mediated acute rejection.Nefrologia200626Suppl. 7153117763623
    [Google Scholar]
  16. GullerogluK. BaskinE. MorayG. OzdemirH. ArslanH. HaberalM. Rituximab therapy and infection risk in pediatric renal transplant patients.Exp. Clin. Transplant.201614217217526742572
    [Google Scholar]
  17. BarmettlerS. OngM.S. FarmerJ.R. ChoiH. WalterJ. Association of immunoglobulin levels, infectious risk, and mortality with Rituximab and hypogammaglobulinemia.JAMA Netw. Open201817e18416910.1001/jamanetworkopen.2018.416930646343
    [Google Scholar]
  18. AlvarezE. LongbrakeE.E. RammohanK.W. StankiewiczJ. HershC.M. Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.Mult. Scler. Relat. Disord.20237910500910.1016/j.msard.2023.10500937783194
    [Google Scholar]
  19. Fernández RodriguezL. AmannR. VerdeE. OrtegaM. AnayaF. Disseminated cryptococosis in renal transplant recipient.Nefrologia2005251737715789540
    [Google Scholar]
  20. NormanB.H. Drug Induced Liver Injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies.J. Med. Chem.20206320113971141910.1021/acs.jmedchem.0c0052432511920
    [Google Scholar]
  21. Pérez-TorresA. González GarciaM.E. San José-ValienteB. Bajo RubioM.A. Celadilla DiezO. López-SobalerA.M. SelgasR. Protein-energy wasting syndrome in advanced chronic kidney disease: Prevalence and specific clinical characteristics.Nefrología (English Edition)201838214115110.1016/j.nefroe.2017.11.01828755901
    [Google Scholar]
  22. KovesdyC.P. GeorgeS.M. AndersonJ.E. Kalantar-ZadehK. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease.Am. J. Clin. Nutr.200990240741410.3945/ajcn.2008.2739019535427
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056353324250302180953
Loading
/content/journals/cmir/10.2174/0115734056353324250302180953
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test